Related Experiment Video
Updated: May 9, 2026

Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Intestinal permeability defects: is it time to treat?
Matthew A Odenwald1, Jerrold R Turner
1Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
The intestinal barrier, crucial for health, can become compromised, leading to "leaky gut." Current evidence suggests this barrier dysfunction is often a symptom, not a cause, of disease.
Area of Science:
- Gastroenterology
- Immunology
- Cell Biology
Background:
- The intestinal epithelium maintains barrier integrity via tight junctions, regulating paracellular transport.
- Increased intestinal permeability (leaky gut) is linked to various intestinal and systemic diseases.
- The exact role of leaky gut in disease pathogenesis remains unclear, with ongoing research.
Purpose of the Study:
- To review the role of intestinal barrier function in health and disease.
- To evaluate the evidence linking increased intestinal permeability to clinical conditions.
- To discuss the concept of "leaky gut syndrome" and its therapeutic implications.
Main Methods:
- Literature review of studies on intestinal barrier function, permeability, and associated diseases.
- Analysis of correlative and mechanistic data from human and animal models.
- Evaluation of proposed therapeutic strategies for barrier restoration.
Main Results:
- Compromised intestinal barrier function is associated with numerous diseases.
- While increased permeability is common in disease, it may be a consequence rather than a cause.
- Current clinical trials have not demonstrated efficacy for barrier restoration treatments.
- Intestinal barrier loss alone is insufficient to initiate disease in experimental models.
Conclusions:
- Increased intestinal permeability is frequently observed in various diseases but its causal role is uncertain.
- The popular diagnosis of "leaky gut syndrome" lacks robust clinical trial support for barrier restoration as a cure.
- Current therapeutic strategies should focus on treating the underlying disease rather than solely on barrier repair.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
